Veterinary Medicine Information website

Nobilis RTV 8544 Lyofilisaat voor vernevelsuspensie Lyofilisaat voor suspensie voor oculonasaal gebruik Lyofilisaat voor gebruik in drinkwater

Not authorised
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RTV 8544 Lyofilisaat voor vernevelsuspensie Lyofilisaat voor suspensie voor oculonasaal gebruik Lyofilisaat voor gebruik in drinkwater
Active substance:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
Target species:
  • Chicken
  • Chicken
Route of administration:
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    Other
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Nobilis RTV 8544 1 Vial with 5000 doses of Lyophilisate for nebuliser suspension
  • Nobilis RTV 8544 1 Vial with 2500 doses of Lyophilisate for nebuliser suspension
  • Nobilis RTV 8544 1 Vial with 500 doses of Lyophilisate for nebuliser suspension
  • Nobilis RTV 8544 1 Vial with 1000 doses of Lyophilisate for nebuliser suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V222022
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/03/2022
Download
Dutch (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
Dutch (PDF)
Published on: 22/03/2022
Download